A significant positive association between GPRC5D expression on MM cells and the efficacy of talquetamab has been reported, along with significant heterogeneity in MM cell surface expression of GPRC5D among MM patients12. The gene discussed is GPRC5D; the disease is Miyoshi myopathy.